Deep brain stimulation is not an approved treatment for autism but has helped some people with extreme obsessions and other severe traits. Host Ben Kuebrich investigates one success story.
Scientists’ desire for evidence-based medical inquiry runs headlong into an apparently immovable obstacle: the U.S. Drug Enforcement Agency.
A new line of female mice may enable researchers to test gene-based therapies for Rett syndrome.
Responding to serious concerns about its policy defining certain kinds of research as ‘clinical trials,’ the U.S. National Institutes of Health has postponed enforcing parts of the policy until September 2019.
The United States has approved a compound derived from marijuana as a treatment for certain types of epilepsy. The ruling may spell good news for autism research.
Papers in medical journals go through rigorous peer review and meticulous data analysis. Yet many of these articles are missing a key piece of information: the financial ties of the authors.
Register for the next Spectrum webinar, featuring Stelios Georgiades, who will present a model for predicting childhood trajectories in individuals with autism.
A new method enables scientists to monitor the activity of key molecules involved in the growth and remodeling of connections in the brain.